Revance Therapeutics, Inc. Quarterly Operating Income (Loss) in USD from Q1 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Revance Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2013 to Q3 2024.
  • Revance Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$32.3M, a 14.1% increase year-over-year.
  • Revance Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$290M, a 1.66% decline year-over-year.
  • Revance Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$317M, a 7.36% increase from 2022.
  • Revance Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$342M, a 24.5% decline from 2021.
  • Revance Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$275M, a 0.55% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$290M -$32.3M +$5.31M +14.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$295M -$34.5M +$21.8M +38.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$317M -$46.8M -$117K -0.25% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$317M -$176M -$31.7M -22% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 -$285M -$37.6M +$39.9M +51.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$325M -$56.3M +$1.5M +2.59% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$326M -$46.7M +$15.5M +24.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$342M -$144M -$82.8M -134% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 -$259M -$77.5M -$4.76M -6.55% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$254M -$57.8M +$12.5M +17.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$267M -$62.2M +$7.79M +11.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$275M -$61.6M +$16.4M +21% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 -$291M -$72.7M +$4.41M +5.71% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$295M -$70.3M -$13.2M -23.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$282M -$70M -$9.05M -14.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$273M -$78M -$31.8M -68.9% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 -$241M -$77.1M -$34.6M -81.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$207M -$57.1M -$18M -46% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$189M -$61M -$24.3M -66.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 -$164M -$46.2M -$7.76M -20.2% Oct 1, 2019 Dec 31, 2019 10-K 2020-02-26
Q3 2019 -$157M -$42.5M -$8.9M -26.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$148M -$39.1M -$4.2M -12% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$144M -$36.6M -$965K -2.71% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$143M -$38.4M -$2.63M -7.36% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-26
Q3 2018 -$140M -$33.6M -$2.93M -9.52% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-26
Q2 2018 -$137M -$34.9M -$8.08M -30.1% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-26
Q1 2018 -$129M -$35.7M -$8.57M -31.7% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-26
Q4 2017 -$120M -$35.8M -$9.12M -34.2% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-26
Q3 2017 -$111M -$30.7M -$13M -73.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-02
Q2 2017 -$98.3M -$26.8M -$2.76M -11.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-03
Q1 2017 -$95.6M -$27.1M -$7.34M -37.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 -$88.2M -$26.7M -$4.88M -22.4% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 -$83.3M -$17.7M +$1.05M +5.57% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-03
Q2 2016 -$84.4M -$24.1M -$7.5M -45.2% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-04
Q1 2016 -$76.9M -$19.7M -$4.57M -30.1% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 -$72.3M -$21.8M -$7.94M -57.3% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-02
Q3 2015 -$64.4M -$18.8M -$4.94M -35.8% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 -$59.4M -$16.6M -$3.7M -28.7% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 -$55.7M -$15.2M -$3.69M -32.1% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$52.1M -$13.8M -$4.92M -55% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-28
Q3 2014 -$47.1M -$13.8M -$5.56M -67.2% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-10
Q2 2014 -$41.6M -$12.9M -$1.54M -13.6% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 -$40M -$11.5M -$1.81M -18.7% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 -$38.2M -$8.93M Oct 1, 2013 Dec 31, 2013 10-K 2016-03-04
Q3 2013 -$8.27M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 -$11.3M Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-13
Q1 2013 -$9.68M Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.